FIGHTING THE PANDEMIC
Oxford’s hope for a coronavirus vaccine: Sarah Gilbert
Supervisor, vaccine development, Jenner Institute at University of Oxford
Before the coronavirus pandemic, few of us would have heard of Gilbert, who made her career studying and developing vaccines for diseases including influenza and Middle East Respiratory Syndrome (Mers). But Covid-19 has made her a mainstay of front pages and broadcast news, as the Oxford team led by Gilbert and Adrian Hill races to produce what may be the first UK-developed vaccine candidate. Oxford’s vaccine, in which patients are administered a fragment of SARS-CoV-2 attached to a harmless adenovirus found in chimps, is already in early human trials; if all goes well, Gilbert hopes to have a million doses ready by September.